Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
MMRC Horizon One: RRMM (MMRC-099)Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseActive, not recruitingPhase 22026-06-05NCT06171685

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Multiple Myeloma Research Consortium9

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Atrium Levine Cancer instituteCharlotteUnited States2
Barbara Ann Karmanos Cancer CenterDetroitUnited States4
Beth Israel Deaconess Medical CenterBostonUnited States462
City of HopeDuarteUnited States238
Dana Farber Cancer Institute/Harvard Medical SchoolBostonUnited States1
Emory Winship Cancer CenterAtlantaUnited States2
Hackensack University Medical CenterHackensackUnited States308
Mayo Clinic RochesterRochesterUnited States133
Memorial Sloan Kettering Cancer CenterNew YorkUnited States16
Mt. Sinai School of MedicineNew YorkUnited States5
Tennessee OncologyNashvilleUnited States77
University of Chicago Cancer CenterChicagoUnited States1
Washington University MedicineSt LouisUnited States3